A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer (Q36872593)
Jump to navigation
Jump to search
scientific article published on 13 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer |
scientific article published on 13 January 2015 |
Statements
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer (English)
Antonio Jimeno
Julie E Bauman
Charles Weissman
Douglas Adkins
Ian Schnadig
Patrice Beauregard
Daniel W Bowles
Alexander Spira
Benjamin Levy
Nagashree Seetharamu
Diana Hausman
Luke Walker
Keisuke Shirai
13 January 2015
1 reference
1 reference
1 reference
1 reference